Basic information
Biomarker: skp2
Histology type: endometrioid endometrial carcinoma
Cohort characteristics
Country: Japan
Region: Kanagawa
Study type: Comparative Study
Followed up time :
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
176 | EEC | 136 | endometrial hyperplasias | 20 | normal endometria | 20 |
Sample information
Conclusion: The skp2 level might have increased due to p27 accumulation and may be a good indicator of proliferative activity and poor prognosis.
Sample type : tissue
Sample method: immunohistochemistry
Expression pattern : high expression((LI≥20%)
Expression elevation: Positive staining was evaluated by counting approximately 1,000 cells in high-power fields and was expressed as the labeling index (LI), which was regarded as the percentage of positive nuclei.
Disease information
Statictics: Median;Range
Cohort age: 57;30-83
Related information
Funtion Uniprot: Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins involved in cell cycle progression, signal transduction and transcription (PubMed:11931757, PubMed:12435635, PubMed:12769844, PubMed:12840033, PubMed:15342634, PubMed:15668399, PubMed:15949444, PubMed:16103164, PubMed:16262255, PubMed:16581786, PubMed:16951159, PubMed:17908926, PubMed:17962192, PubMed:22770219, PubMed:32267835). Specifically recognizes phosphorylated CDKN1B/p27kip and is involved in regulation of G1/S transition (By similarity). Degradation of CDKN1B/p27kip also requires CKS1. Recognizes target proteins ORC1, CDT1, RBL2, KMT2A/MLL1, CDK9, RAG2, FOXO1, UBP43, YTHDF2, and probably MYC, TOB1 and TAL1 (PubMed:11931757, PubMed:12435635, PubMed:12769844, PubMed:12840033, PubMed:15342634, PubMed:15668399, PubMed:15949444, PubMed:16103164, PubMed:17962192, PubMed:16581786, PubMed:16951159, PubMed:17908926, PubMed:32267835). Degradation of TAL1 also requires STUB1 (PubMed:17962192). Recognizes CDKN1A in association with CCNE1 or CCNE2 and CDK2 (PubMed:16262255). Promotes ubiquitination and destruction of CDH1 in a CK1-dependent manner, thereby regulating cell migration (PubMed:22770219).Through the ubiquitin-mediated proteasomal degradation of hepatitis C virus non-structural protein 5A, has an antiviral activity towards that virus.
UniProt ID: Q13309
UniProt Link: https://www.uniprot.org/uniprotkb/Q13309/entry
Biological function from UniProt: #Antiviral defense #Host-virus interaction #Immunity #Innate immunity #Ubl conjugation pathway
Molecular function from UniProt:
Subcellular UniProt: #Cytoplasm #Nucleus
Alternative name from UniProt:
Recommended name: S-phase kinase-associated protein 2
Gene name from HGNC: SKP2 (FBL1, FBXL1, p45)
HPA class: Cancer-related genes
AlphaFold DB: Q13309
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/Q13309
HPA link: https://www.proteinatlas.org/ENSG00000145604-SKP2
Tissue specificity RNA from HPA: Tissue enhanced (placenta)
Tissue expression from HPA: Nuclear and cytoplasmic expression in placenta.
Single cell type specificity Group enriched (Extravillous trophoblasts, Cytotrophoblasts, Syncytiotrophoblasts)
Immune cell specificity: Low immune cell specificity
Subcellular summary HPA Located in Nucleoplasm, Cytosol (CCD Transcript)
Cancer prognostic summary HPA Prognostic marker in renal cancer (unfavorable), melanoma (unfavorable) and ovarian cancer (favorable)
Pathology link: https://www.proteinatlas.org/ENSG00000145604-SKP2/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000145604-SKP2/pathology/endometrial+cancer
OMIM: 601436
OMIM link2: https://www.omim.org/entry/601436
HGNC ID: HGNC:10901
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:10901